To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

Canavan Foundation


450 West End Avenue, #6A
New York, NY 10024 USA





800 Number


Email Address

[email protected]


The Canavan Foundation (CF) is a non-profit organization founded in 1992 by parents and friends of children with Canavan disease. The mission of the Canavan Foundation is to provide the latest information (including a list of testing sites) for the at-risk population, educate medical and other professional communities, and to support research. Canavan disease is a rare, inherited neurological disorder caused by an enzyme deficiency and characterized by poor muscle tone, progressive mental decline, poor head control, and/or blindness. Symptoms usually become apparent when an infant is three to nine months old. Currently there is no cure for the disease.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.